Literature DB >> 17621244

The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health.

Emilia H Koumans1, Maya Sternberg, Carol Bruce, Geraldine McQuillan, Juliette Kendrick, Madeline Sutton, Lauri E Markowitz.   

Abstract

OBJECTIVES: Bacterial vaginosis (BV), a disturbance of vaginal microflora, is a common cause of vaginal symptoms and is associated with an increased risk of acquisition of sexually transmitted infections, HIV, and with adverse pregnancy outcomes. We determined prevalence and associations with BV among a representative sample of women of reproductive age in the United States. STUDY
DESIGN: Women aged 14-49 years participating in the National Health and Nutrition Examination Survey 2001-2004 were asked to submit a self-collected vaginal swab for Gram staining. BV, determined using Nugent's score, was defined as a score of 7-10.
RESULTS: The prevalence of BV was 29.2% (95% confidence interval 27.2%-31.3%) corresponding to 21 million women with BV; only 15.7% of the women with BV reported vaginal symptoms. Prevalence was 51.4% among non-Hispanic blacks, 31.9% among Mexican Americans, and 23.2% among non-Hispanic whites (P <0.01 for each comparison). Although BV was also associated with poverty (P <0.01), smoking (P <0.05), increasing body mass index (chi2 P <0.0001 for trend), and having had a female sex partner (P <0.005), in the multivariate model, BV only remained positively associated with race/ethnicity, increasing lifetime sex partners (chi2 P <0.001 for trend), increasing douching frequency (chi2 P for trend <0.001), low educational attainment (P <0.01), and inversely associated with current use of oral contraceptive pills (P <0.005).
CONCLUSION: BV is a common condition; 84% of women with BV did not report symptoms. Because BV increases the risk of acquiring sexually transmitted infections, BV could contribute to racial disparities in these infections.

Entities:  

Mesh:

Year:  2007        PMID: 17621244     DOI: 10.1097/OLQ.0b013e318074e565

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  243 in total

1.  Prevalence of bacterial vaginosis and Candida among postmenopausal women in the United States.

Authors:  Joscelyn N Hoffmann; Hannah M You; E C Hedberg; Jeanne A Jordan; Martha K McClintock
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-11       Impact factor: 4.077

2.  A case control study of anovaginal distance and bacterial vaginosis.

Authors:  R M Brotman; J H Melendez; K G Ghanem
Journal:  Int J STD AIDS       Date:  2011-04       Impact factor: 1.359

Review 3.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Authors:  Rebecca M Brotman
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

4.  Emerging Sexual Health Issues Among Women Who Have Sex with Women.

Authors:  Jeanne M Marrazzo; Linda M Gorgos
Journal:  Curr Infect Dis Rep       Date:  2012-02-02       Impact factor: 3.725

5.  Chlamydia trachomatis infection among women reporting sexual activity with women screened in Family Planning Clinics in the Pacific Northwest, 1997 to 2005.

Authors:  Devika Singh; David N Fine; Jeanne M Marrazzo
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

6.  Comparisons of vaginal flora patterns among sexual behaviour groups of women: implications for the pathogenesis of bacterial vaginosis.

Authors:  Kristin M Olson; Louis J Boohaker; Jane R Schwebke; Stella Aslibekyan; Christina A Muzny
Journal:  Sex Health       Date:  2018-02       Impact factor: 2.706

7.  Beyond douching: use of feminine hygiene products and STI risk among young women.

Authors:  Mary A Ott; Susan Ofner; J Dennis Fortenberry
Journal:  J Sex Med       Date:  2009-01-12       Impact factor: 3.802

Review 8.  Placental colonization with periodontal pathogens: the potential missing link.

Authors:  Lori A Fischer; Ellen Demerath; Peter Bittner-Eddy; Massimo Costalonga
Journal:  Am J Obstet Gynecol       Date:  2019-04-30       Impact factor: 8.661

9.  Molecular analysis of the relationship between specific vaginal bacteria and bacterial vaginosis metronidazole therapy failure.

Authors:  B Wang; B B Xiao; C G Shang; K Wang; R S Na; X X Nu; Q Liao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-10       Impact factor: 3.267

10.  Association between obesity and bacterial vaginosis as assessed by Nugent score.

Authors:  Rita T Brookheart; Warren G Lewis; Jeffrey F Peipert; Amanda L Lewis; Jenifer E Allsworth
Journal:  Am J Obstet Gynecol       Date:  2019-01-29       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.